hVIVO to have a high profile at World Vaccine Congress Europe, 9 – 11 November 2015, Silken Puerta América, Madrid, Spain
As Gold sponsor at this leading event in the global vaccine calendar, hVIVO will not only have speaker presence featuring Director of Project Support and Challenge Agent Development, Dr Andrew Catchpole, but will have poster presentations and an exhibition presence to offer more information on the pioneering human viral challenge model.
World Vaccine Congress spans research, development and strategic partnering for the vaccine industry and through strategic keynote plenaries, themed tracks and dedicated networking sessions, the three day programme promises to be one of the most comprehensive in Europe.
Dr Catchpole is presenting on Day Two (10 November) and his presentation title is : “Human viral challenge studies: Accelerating drug development.”
This presentation will provide useful guidance for larger field based studies that the human viral challenge model has been shown to be predictive and will touch on several case studies.
The first hVIVO scientific poster is entitled: “High Throughput use of the Haemagglutination Inhibition Assay During Phase 3 Clinical Trials Using Large Virus Panels” and is authored by Daryl Borley, Marianne Jacquet, Andrew Catchpole, Rob Lambkin-Williams, Lynne Batty, Peter Sargent and Nicolas Noulin.
The second scientific poster is entitled: “Development of ViruSpot imaging technology for high throughput measurement of RSV-neutralising antibodies during vaccine trials” and is authored by Kate Carney, Daryl Borley, Thomas Hand and Peter Sargent.
To find out more about this event visit the Congress website here .
If you would like to make contact with Dr Andrew Catchpole or any attending colleagues before or during the event, or to speak to our Business Development team, please use the enquiry form below.